The tumor inhibition effect of PI4KB-Peptide-1 surpasses that of chloroquine in immune-competent mice but is similar in immune-deficient mice, suggesting that PI4KB-Peptide-1 positively regulates the immune response more effectively than chloroquine. Here, PI4KB is linked to neoplasm.